 Connection
Kennon Heard to Antivenins
This is a "connection" page, showing publications Kennon Heard has written about Antivenins.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.909 |
|
|
|
-
Hoyte CO, Cushing TA, Heard KJ. Anaphylaxis to black widow spider antivenom. Am J Emerg Med. 2012 Jun; 30(5):836.e1-2.
Score: 0.393
-
Heard K, O'Malley GF, Dart RC. Antivenom therapy in the Americas. Drugs. 1999 Jul; 58(1):5-15.
Score: 0.161
-
Dart RC, Bush SP, Heard K, Arnold TC, Sutter M, Campagne D, Holstege CP, Seifert SA, Lo JCY, Quan D, Borron S, Meurer DA, Burnham RI, McNally J, Garcia-Ubbelohde W, Anderson VE. The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(ab')2 Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial. Ann Emerg Med. 2019 09; 74(3):439-449.
Score: 0.158
-
Dart RC, Bogdan G, Heard K, Bucher Bartelson B, Garcia-Ubbelohde W, Bush S, Arnold T, Clark RC, Hendey GW, Holstege C, Spradley EA. A randomized, double-blind, placebo-controlled trial of a highly purified equine F(ab)2 antibody black widow spider antivenom. Ann Emerg Med. 2013 Apr; 61(4):458-67.
Score: 0.103
-
Monte AA, Bucher-Bartelson B, Heard KJ. A US perspective of symptomatic Latrodectus spp. envenomation and treatment: a National Poison Data System review. Ann Pharmacother. 2011 Dec; 45(12):1491-8.
Score: 0.095
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|